Treatment inferred from mutations identified using massive parallel sequencing leads to clinical benefit in some heavily pretreated cancer patients

Aviad Zick*, Tamar Peretz, Michal Lotem, Ayala Hubert, Daniela Katz, Mark Temper, Yakir Rottenberg, Beatrice Uziely, Hovav Nechushtan, Amichai Meirovitz, Amir Sonnenblick, Eli Sapir, David Edelman, Yael Goldberg, Alexander Lossos, Shai Rosenberg, Iris Fried, Ruth Finklstein, Eli Pikarsky, Hanoch Goldshmidt

*Corresponding author for this work

Research output: Contribution to journal › Article › peer-review

2 Scopus citations

Fingerprint

Dive into the research topics of 'Treatment inferred from mutations identified using massive parallel sequencing leads to clinical benefit in some heavily pretreated cancer patients'. Together they form a unique fingerprint.

Keyphrases

Medicine and Dentistry